August 3, 2022
NOT-CA-21-121 - Notice of Special Interest (NOSI): Dietary Effects on Nutrient Sensing Pathways in Tumor Etiology and Prevention
National Cancer Institute (NCI)
The purpose of this notice is to amend NOT-CA-21-121 "Notice of Special Interest (NOSI): Dietary Effects on Nutrient Sensing Pathways in Tumor Etiology and Prevention" with updates to the Related Announcements and Application and Submission Information.
Related Announcements
Currently reads:
PAR-19-133- Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 - Clinical Trial Required)
PAR-19-134- Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed
PA-20-185- NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)
PA-20-188- NIH Pathway to Independence Award (Parent K99/R00 - Independent Clinical Trial Not Allowed)
PAR-20-292- NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional)
PAR-21-038- Stephen I. Katz Early-Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed)
PAR-21-300- NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 Independent Clinical Trial Not Allowed)
PAR-21-301- NCI Transition Career Development Award to Promote Diversity (K22 Independent Clinical Trial Not Allowed)
Modified to read (in bold italics):
PAR-19-133- Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 - Clinical Trial Required)
PAR-19-134- Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed
PA-20-185- NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)
PA-20-188- NIH Pathway to Independence Award (Parent K99/R00 - Independent Clinical Trial Not Allowed)
PAR-20-292- NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional)
PAR-21-038- Stephen I. Katz Early-Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed)
PAR-21-300- NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 Independent Clinical Trial Not Allowed)
PAR-21-301- NCI Transition Career Development Award to Promote Diversity (K22 Independent Clinical Trial Not Allowed)
PA-20-195 - NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed)
Application and Submission Information
Currently reads:
This notice applies to due dates on or after February 5, 2022, and subsequent receipt dates through September 8, 2024.
Submit applications for this initiative using one of the following funding opportunity announcements (FOAs) or any reissues of these announcement through the expiration date of this notice.
|
Activity Code |
FOA Title |
First Available Due Date |
|
Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 - Clinical Trial Required) |
February 25, 2022 |
|
|
Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed |
February 25, 2022 |
|
|
NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed) |
February 5, 2022 |
|
|
NIH Pathway to Independence Award (Parent K99/R00 - Independent Clinical Trial Not Allowed) |
February 12, 2022 |
|
|
NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional) |
February 22, 2022 |
|
|
Stephen I. Katz Early-Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed) |
January 26, 2022 |
|
|
NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 - Independent Clinical Trial Not Allowed) |
February 12, 2022 |
|
|
NCI Transition Career Development Award to Promote Diversity (K22 Independent Clinical Trial Not Allowed) |
February 12, 2022 |
Modified to read (in bold italics):
This notice applies to due dates on or after February 5, 2022, and subsequent receipt dates through September 8, 2024.
Submit applications for this initiative using one of the following funding opportunity announcements (FOAs) or any reissues of these announcement through the expiration date of this notice.
|
Activity Code |
FOA Title |
First Available Due Date |
|
Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 - Clinical Trial Required) |
February 25, 2022 |
|
|
Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed |
February 25, 2022 |
|
|
NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed) |
February 5, 2022 |
|
|
NIH Pathway to Independence Award (Parent K99/R00 - Independent Clinical Trial Not Allowed) |
February 12, 2022 |
|
|
NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional) |
February 22, 2022 |
|
|
Stephen I. Katz Early-Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed) |
January 26, 2022 |
|
|
NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 - Independent Clinical Trial Not Allowed) |
February 12, 2022 |
|
|
NCI Transition Career Development Award to Promote Diversity (K22 Independent Clinical Trial Not Allowed) |
February 12, 2022 |
|
|
NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed) |
October 16, 2022 |
All other aspects of the FOA remain unchanged.
Phillip J. Daschner, MSc
National Cancer Institute (NCI)
Telephone: 240-276-6227
Email: [email protected]
Sharon Ross, PhD, MPH
National Cancer Institute (NCI)
Telephone: 240-276-7124
Email: [email protected]
Amit Kumar, PhD
National Cancer Institute (NCI)
Telephone: 240-276-7617
Email: [email protected]
and Human Services (HHS)
